Search results for "Substance-Related Disorders"

showing 10 items of 140 documents

Sample size in cluster-randomized trials with time to event as the primary endpoint

2011

In cluster-randomized trials, groups of individuals (clusters) are randomized to the treatments or interventions to be compared. In many of those trials, the primary objective is to compare the time for an event to occur between randomized groups, and the shared frailty model well fits clustered time-to-event data. Members of the same cluster tend to be more similar than members of different clusters, causing correlations. As correlations affect the power of a trial to detect intervention effects, the clustered design has to be considered in planning the sample size. In this publication, we derive a sample size formula for clustered time-to-event data with constant marginal baseline hazards…

Statistics and ProbabilityTime FactorsEndpoint DeterminationSubstance-Related DisordersEpidemiologyPsychological interventionBiostatisticsTime-to-Treatmentlaw.inventionCorrelationRandom AllocationRandomized controlled triallawStatisticsClinical endpointEconometricsCluster AnalysisHumansPoisson DistributionBaseline (configuration management)Randomized Controlled Trials as TopicMathematicsEvent (probability theory)Likelihood FunctionsModels StatisticalTerm (time)Sample size determinationSample SizeRegression AnalysisSubstance Abuse Treatment CentersStatistics in Medicine
researchProduct

Public availability of published research data in substance abuse journals

2014

[EN] Sharing research data is an increasingly necessary requirement for the advancement of science. The aim of this study was to analyse the policies on openness in sharing scientific research data in substance abuse journals. Journals included in the Substance abuse area of the Journal Citation Reports were used for the analysis, with reference to the instructions to authors published on the journals websites. In 67.6% of the journals, it is possible to store materials in thematic or institutional repositories; 47% accept supplemental material; 64.7% allow the reuse of data, and 41.2% admit the publication of their data on a website. Most journals recommend that authors deposit their data …

Substance-Related DisordersInternet privacyMedicine (miscellaneous)Poison controlOpen research dataBIBLIOTECONOMIA Y DOCUMENTACIONSharing dataReuseSuicide preventionAccess to InformationOpenness to experiencemedicineHumansGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Data CurationSubstance abuse journalsImpact factorbusiness.industryHealth PolicyHuman factors and ergonomicsmedicine.diseaseSubstance abuseJournal Impact FactorPeriodicals as TopicCitationbusiness
researchProduct

Analysis of hospital costs by morbidity group for patients with severe mental illness

2022

The goal of this study is to analyse hospital costs and length of stay of patients admitted to psychiatric units in hospitals in a European region of the Mediterranean Arc. The aim is to identify the effects of comorbidities and other variables in order to create an explanatory cost model.In order to carry out the study, the Ministry of Health was asked to provide data on access to the mental health facilities of all hospitals in the region. Among other questions, this database identifies the most important diagnostic variables related to admission, like comorbidities, age and gender. The method used, based on the Manning-Mullahy algorithm, was linear regression. The results were measured b…

Substance-Related DisordersMental DisordersHospitals AdministracióHumansGeneral MedicineHospital CostsLength of StayMorbiditySalut mentalHospitals
researchProduct

Comparing illicit drug use in 19 European cities through sewage analysis

2012

Abstract: The analysis of sewage for urinary biomarkers of illicit drugs is a promising and complementary approach for estimating the use of these substances in the general population. For the first time, this approach was simultaneously applied in 19 European cities, making it possible to directly compare illicit drug loads in Europe over a 1-week period. An inter-laboratory comparison study was performed to evaluate the analytical performance of the participating laboratories. Raw 24-hour composite sewage samples were collected from 19 European cities during a single week in March 2011 and analyzed for the urinary biomarkers of cocaine, amphetamine, ecstasy, methamphetamine and cannabis u…

Time FactorsEcstasysewage biomarker analysis ; cocaine ; methamphetamine ; amphetamine ; MDMA ; CannabisSewageWaste Disposal FluidMethamphetamineCocaineTandem Mass SpectrometryAigües residualsPer capitaWaste Management and Disposaleducation.field_of_studybiologySewageSewage biomarker analysisMDMAPollutionEuropeChemistryGeographyPopulation Surveillancemedicine.drugEnvironmental MonitoringEnvironmental EngineeringMDMASubstance-Related DisordersPopulationEnvironmental healthmedicineEnvironmental ChemistryIllicit drugHumansCitieseducationBiologyCannabisbusiness.industryCannabinoidsIllicit DrugsAmphetaminesEnvironmental engineeringbiology.organism_classificationAmphetamineCannabisDroguesbusinessBiomarkersWater Pollutants ChemicalWaste disposalChromatography LiquidThe science of the total environment
researchProduct

The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013a)

2014

In response to our suggestion to define substance use disorders via ‘heavy use over time’, theoretical and conceptual issues, measurement problems and implications for stigma and clinical practice were raised. With respect to theoretical and conceptual issues, no other criterion has been shown, which would improve the definition. Moreover, heavy use over time is shown to be highly correlated with number of criteria in current DSM-5. Measurement of heavy use over time is simple and while there will be some underestimation or misrepresentation of actual levels in clinical practice, this is not different from the status quo and measurement of current criteria. As regards to stigma, research ha…

Time FactorsSubstance-Related DisordersStatus quomedia_common.quotation_subjectSocial StigmaCommon denominatorGeneral Medicinemedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersSubstance abuseClinical PracticeMisrepresentationmedicineHumansSubstance usePsychologySocial psychologymedia_common
researchProduct

Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes

2017

Several treatment options for gambling disorder (GD) have been tested in recent years; however dropout levels still remain high. This study aims to evaluate whether the presence of psychiatric comorbidities predicts treatment outcome according to Millon's evolutionary theory, following a six-month therapy for GD. The role of severity, duration of the disorder, typology of gambling (mainly online or offline) and pharmacological treatment were also analysed. The recruitment included 194 pathological gamblers (PGs) to be compared with 78 healthy controls (HCs). Psychological assessment included the South Oaks Gambling Screen and the Millon Clinical Multiaxial Inventory-III. The "treatment fail…

TypologyAdultMalemedicine.medical_specialtyPatient DropoutsAdolescentSubstance-Related Disorders030508 substance abuseComorbidityPersonality DisordersStress Disorders Post-Traumatic03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansPsychological testingTreatment FailurePsychiatryPathologicalSettore MED/25 - PsichiatriaBiological PsychiatryDropout (neural networks)AgedAntisocial personality disorderAntisocial Personality DisorderSyndromeMiddle Agedmedicine.diseasePersonality disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthPassive-Aggressive Personality DisorderCase-Control StudiesGamblingGambling disorderFemale0305 other medical sciencePsychologyGambling disorder Dropout Treatment outcome Personality disorders Clinical syndromes Psychiatric disorders Disordered gambling Pathological gamblingClinical psychology
researchProduct

Use of dietary supplements and anabolic-androgenic steroids among Finnish adolescents in 1991-2005.

2009

Background : The aim of the study was to describe the prevalence, trends and associated factors of dietary supplements (DS) and anabolic-androgenic steroids (AAS) use among Finnish adolescents. Methods: The sample comprised 30 511 adolescents aged 12–18 years, of which 22 519 (74%) answered a questionnaire. We also studied associations between 14 socioeconomic, health and health behavioural variables and DS and AAS use by logistic regression. Results: The proportion of respondents using DS was 45% during the past year and it increased linearly by age. Vitamins (37%) and herbal products (13%) were the most common DSs. In 1991, 9% of the boys aged 16–18 years reported protein use, while the f…

VitaminMalemedicine.medical_specialtyPediatricsAdolescentSubstance-Related DisordersPhysical exerciseLogistic regressionchemistry.chemical_compoundAlcohol intoxicationAnabolic AgentsRisk FactorsSurveys and QuestionnairesEpidemiologymedicinePrevalenceHumansSex DistributionChildSocioeconomic statusFinlandDoping in Sportsbusiness.industryPublic healthPublic Health Environmental and Occupational HealthVitaminsmedicine.diseaseSubstance abuseLogistic ModelschemistrySocioeconomic FactorsAdolescent BehaviorDietary SupplementsFemaleSteroidsDietary ProteinsbusinessDemographyEuropean journal of public health
researchProduct

Externalizing Behaviors and Cigarette Smoking as Predictors for Use of Illicit Drugs: A Longitudinal Study Among Finnish Adolescent Twins

2010

We examined whether externalizing problem behaviors (hyperactivity–impulsivity, aggressiveness, and inattention) predict illicit drug use independently, or whether their associations with drug use are mediated through cigarette smoking. We used a prospective longitudinal design within theFinnTwin12-17study among Finnish adolescents with baseline at age 12 and follow-up surveys at ages 14 and 17. Path models were conducted withMplusand included 1992 boys and 2123 girls. The outcome was self-reported ever use of cannabis or other illicit drugs at age 17. The predictors were: externalizing behaviors (hyperactivity–impulsivity, aggressiveness, and inattention) assessed by teachers and parents (…

cannabisMaleLongitudinal studyexternalizing behaviorPsychological interventioncigarette smokinginattentiontobacco0302 clinical medicineadolescents030212 general & internal medicineLongitudinal StudiesProspective StudiesProspective cohort studyChildGenetics (clinical)FinlandInternal-External Controlmedia_commonbiologySmokingObstetrics and Gynecologyhyperactivity-impulsivitySubstance Abuse DetectionConduct disorderTwin Studies as TopicFemalePsychologyDrugConduct Disordermedicine.medical_specialtyMediation (statistics)AdolescentSubstance-Related Disordersmedia_common.quotation_subjectillicit drugsArticle03 medical and health sciencesCigarette smokingmedicineHumansPsychiatryIllicit Drugsaggressivenessmedicine.diseasebiology.organism_classificationAdolescent BehaviorPediatrics Perinatology and Child HealthCannabisDevelopmental Psychopathology030217 neurology & neurosurgery
researchProduct

Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis

2014

Aims To perform wastewater analyses to assess spatial differences and temporal changes of illicit drug use in a large European population. Design Analyses of raw wastewater over a 1-week period in 2012 and 2013. Setting and Participants Catchment areas of wastewater treatment plants (WWTPs) across Europe, as follows: 2012: 25 WWTPs in 11 countries (23 cities, total population 11.50 million); 2013: 47 WWTPs in 21 countries (42 cities, total population 24.74 million). Measurements Excretion products of five illicit drugs (cocaine, amphetamine, ecstasy, methamphetamine, cannabis) were quantified in wastewater samples using methods based on liquid chromatography coupled to mass spectrom…

cannabisTime FactorsEcstasyEcstasyMethamphetaminesMedicine (miscellaneous)SewageWaste Disposal FluidMass SpectrometryMethamphetamineCocaineMedicineWater treatmentDrug useAmphetamine; cannabis; cocaine; drugs of abuse; ecstasy; methamphetamine; sewagebiologySewageAmphetamine ; Cannabis ; Cocaine ; Drugs of abuse ; Ecstasy ; Methamphetamine ; Sewage6. Clean waterEuropeSubstance Abuse DetectionSubstance abusePsychiatry and Mental healthWastewaterPopulation SurveillanceDrug Abuse And AlcoholismEnvironmental Monitoringdrugs of abuseDrugs of abusemedicine.medical_specialtySubstance-Related DisordersN-Methyl-34-methylenedioxyamphetaminecocaineEnvironmental healthHumanssewageIllicit drugPsychiatryecstasyCannabisCannabinoidsIllicit Drugsbusiness.industryAmphetaminesResearch ReportsEuropean populationmedicine.diseasebiology.organism_classificationMetropolitan areaAmphetamineHuman medicineCannabisbusinessWater Pollutants ChemicalChromatography Liquid
researchProduct

Type 1 diabetes in an adolescent with social problems and mental disorders – case report

2021

W cukrzycy typu 1 przerwanie leczenia (insulinoterapii) prowadzi do cukrzycowej kwasicy ketonowej (DKA), będącej stanem bezpośredniego zagrożenia życia. Celem przedstawionego opisu przypadku jest zwrócenie uwagi na sytuację pacjentów z cukrzycą typu 1 i istotnymi problemami socjalnymi/psychicznymi, którzy ze względu na brak odpowiednich uregulowań prawnych „wypadają z systemu”, który mógłby zapewnić im odpowiednią opiekę warunkującą prawidłowe leczenie. Zaburzenia psychiczne i/lub problemy socjalne utrudniają lub uniemożliwiają prowadzenie samokontroli i leczenia. Pacjenci tacy stanowią istotne wyzwanie dla zespołu diabetologicznego i wymagają zindywidualizowanego postępowania ze strony sys…

diabetes mellitus type 1medicine.medical_specialtyType 1 diabeteszaburzenia związane z substancjami psychoaktywnymiDiabetic ketoacidosisbusiness.industryInsulinmedicine.medical_treatmentGeneral Medicinecukrzyca typu 1 u dziecimedicine.diseaseSocial issuesDiabetes treatmentDiscontinuationmental disorderssubstance-related disordersDiabetes mellitusmedicineProper treatmentIntensive care medicinebusinesszaburzenia psychiatrycznePediatric Endocrinology, Diabetes and Metabolism
researchProduct